Logan R Wilks

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Escherichia Coli

Highly Efficient

High Fat Diet Induced

Top Venues

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Logan R Wilks, Gaurav Joshi, Natalie Rychener, Harvinder Singh Gill
Generation of Broad Protection against Influenza with Di-Tyrosine-Cross-Linked M2e Nanoclusters. ACS infectious diseases (2024)
Logan R Wilks, Gaurav Joshi, Natalie Rychener, Harvinder Singh Gill
Generation of Broad Protection against Influenza with Di-Tyrosine-Cross-Linked M2e Nanoclusters. ACS infectious diseases 10 (5) (2024)
Logan R Wilks, Gaurav Joshi, Natalie Rychener, Harvinder Singh Gill
Generation of Broad Protection against Influenza with Di-Tyrosine-Cross-Linked M2e Nanoclusters. ACS infectious diseases 10 (5) (2024)
Logan R Wilks, Gaurav Joshi, Sang-Moo Kang, Bao-Zhong Wang, Harvinder Singh Gill
Peptide Cross-Linking Using Tyrosine Residues Facilitated by an Exogenous Nickel-Histidine Complex: A Facile Approach for Enhancing Vaccine-Specific Immunogenicity. ACS infectious diseases (2022)
Logan R Wilks, Gaurav Joshi, Megan R Grisham, Harvinder Singh Gill
Tyrosine-Based Cross-Linking of Peptide Antigens to Generate Nanoclusters with Enhanced Immunogenicity: Demonstration Using the Conserved M2e Peptide of Influenza A. ACS infectious diseases 7 (9) (2021)